“Flash Testing System” making it possible for nucleic acid testing done in 30 minutes
On September 5, a new COVID-19 testing device called “Flash Testing System” was released, which is invented by Joint Prevention and Control Mechanism of the State Council R&D team.The new testing device is now displayed in the exhibition area for public health epidemic prevention sector in 2020’s China International Fair for Trade in Service.
The new system is more advanced compared to common nucleic acid testing approaches,as it costs only 30 minutes to obtain a result highly accordant with the most stable products in market without the necessity for a P2 level laboratory or manual draining procedure.
Li Xiang, the founder of this testing system’s undertaking unit named Coyote Biotechnology introduced, “Novel Coronavirus is a type of RNA virus, that’s why reverse transcription, the process in which RNA reverses to DNA, is required after extraction. In our new system, extraction, reverse transcription and expansion can be finished simultaneously, which means every step of reaction can be finished in seconds, and the enzyme used in reaction and the reaction system are unique as well.
Apart from the impressive testing speed, the accuracy of the testing system is reliable as well.
Tan Wenjie, the director of Viral Disease Emergency Center of Disease Prevention and Control Center under Chinese Center for Disease Control and Prevention, told Science and Technology Daily that the possibility of polluted results mistakenly tested positive has been greatly reduced due to the full enclosing “Flash Testing System.” “In effect, there has always been several different kinds of coronavirus spreading among people, triggering upper respiratory infection symptoms like flu does. According to our laboratorial examination, however, even in circumstances with high level of virus, our “Flash Testing System” can remain accurate.”
The reason why the “Flash Testing System” can be invented so rapidly, helping finish the quick-testing mission in the course of the outbreak, can be attributed to the core international patented technology owned by our enterprises, as well as the promoting effect that Industry-University-Research Collaboration has for achievements in science and technology to implement.
By report, “Flash Testing System” got approved for marketing on July 13 by National Medical Products Administration (NMPA) and had been put into use in institutions including Peking Union Medical College Hospital, Shulan Hospital (Hangzhou) and Beijing Tongren Hospital, and did great favor to the prevention and control of epidemic in Xinjiang Province.